Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Total Current Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Current Liabilities ₹973 Cr₹683 Cr₹710 Cr₹526 Cr₹685 Cr

What is the latest Total Current Liabilities ratio of NATCO PHARMA ?

The latest Total Current Liabilities ratio of NATCO PHARMA is ₹973 Cr based on Mar2024 Consolidated results.
Year Total Current Liabilities
Mar2024₹973 Cr
Mar2023₹683 Cr
Mar2022₹710 Cr
Mar2021₹526 Cr
Mar2020₹685 Cr

How is Total Current Liabilities of NATCO PHARMA Trending?

Years Total Current Liabilities % Change
Mar2024 ₹973 Cr
42.41
Mar2023 ₹683 Cr
-3.84
Mar2022 ₹710 Cr
35.16
Mar2021 ₹526 Cr
-23.30
Mar2020 ₹685 Cr -

Compare Total Current Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,070.4 Cr -5.4% 2.3% -17.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,778.0 Cr 2.3% 5.6% 21.7% Stock Analytics
DIVIS LABORATORIES ₹161,949.0 Cr 1.5% 4.2% 51.2% Stock Analytics
CIPLA ₹123,222.0 Cr 0% 2.9% 10% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,205.0 Cr 0.6% 0.9% 23.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,707.7 Cr 0.8% 1.8% -5.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-5.4%

2.3%

-17.5%

SENSEX

0.9%

4.2%

8.3%


You may also like the below Video Courses